Science Translational Medicine

Top Research Topics at Science Translational Medicine?

The topics of Immunology, Cancer research, Internal medicine, Immune system and Pathology are the focal point of discussions in the journal. Science Translational Medicine focuses on Immunology as well as the interrelated topic of Virology. More specifically, the research on Virology in it is related to Virus.

The Cancer research works featured in the journal incorporate elements from Cancer cell, Cancer and Immunotherapy. Topics in Internal medicine explored in the journal were investigated in conjunction with research in Endocrinology, Oncology and Cardiology.

• Immunology (21.07%)
• Cancer research (15.41%)
• Internal medicine (15.19%)

What are the most cited papers published in the journal?

• Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies (2713 citations)
• Genotypic and Histological Evolution of Lung Cancers Acquiring Resistance to EGFR Inhibitors (2385 citations)
• Hidden Killers: Human Fungal Infections (2201 citations)

Research areas of the most cited articles at Science Translational Medicine:

The published articles are organized to address concerns in the fields of Immunology, Cancer research, Internal medicine, Pathology and Cancer. The Immunology research presented in the journal publications focuses mostly on Virology and, on occasion, topics in Epitope. The published papers hold forums on Internal medicine that merge themes from other disciplines such as Endocrinology and Oncology.

What topics the last edition of the journal is best known for?

• Internal medicine
• Gene
• Cancer

The previous edition focused in particular on these issues:

The journal covers a variety of subjects, including Cancer research, Immune system, Antibody, Immunology and Virology. Issues in Cancer research were discussed, taking into consideration concepts from other disciplines like T cell, Cancer, Immunotherapy and Antigen. Studies on T cell discussed in it link to the field of CD8.

The work tackled in Science Translational Medicine goes beyond the discipline of Antibody as it also encompasses Immunity. Immunology works presented in it have a specific focus on Inflammation. The studies in Virology featured incorporate elements of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Coronavirus disease 2019 (COVID-19).

The most cited articles from the last journal are:

• IgA dominates the early neutralizing antibody response to SARS-CoV-2. (268 citations)
• Enhanced SARS-CoV-2 neutralization by dimeric IgA. (108 citations)
• The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. (69 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

Top authors and change over time

The top authors publishing in Science Translational Medicine (based on the number of publications) are:

• Samir Damani (30 papers) absent at the last edition,
• Kelly LaMarco (20 papers) absent at the last edition,
• Chetan Bettegowda (20 papers) published 1 paper at the last edition,
• Robert Langer (20 papers) absent at the last edition,
• Christoph Buettner (19 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Top affiliations and change over time

Only papers with recognized affiliations are considered

The top affiliations publishing in Science Translational Medicine (based on the number of publications) are:

• Harvard University (456 papers) published 41 papers at the last edition, 5 more than at the previous edition,
• National Institutes of Health (304 papers) published 36 papers at the last edition, 7 more than at the previous edition,
• University of California, San Francisco (209 papers) published 11 papers at the last edition, 7 less than at the previous edition,
• Stanford University (205 papers) published 9 papers at the last edition, 14 less than at the previous edition,
• University of Pennsylvania (200 papers) published 14 papers at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 1.92% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 39.22% were posted by at least one author from the top 10 institutions publishing in the journal. Another 14.38% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 18.95% of all publications and 27.45% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

• Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
• Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
• Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
• Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
• Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.